On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Sylvester Comprehensive Cancer Center

InstitutionResearch output, impact & collaborations

Sylvester Comprehensive Cancer Center is a institution indexed in ScholarIQ from OpenAlex.

What is known about Sylvester Comprehensive Cancer Center?

ScholarIQrecord summary

Sylvester Comprehensive Cancer Center is a research organisation in Miami, US. OpenAlex records 11,622 works and 1,039,211 citations for it. 2,457 researchers list it as their most recent affiliation.

How many works does Sylvester Comprehensive Cancer Center have?

ScholarIQindexed works

Sylvester Comprehensive Cancer Center has 11,622 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Sylvester Comprehensive Cancer Center have?

ScholarIQcitation count

Sylvester Comprehensive Cancer Center has 1,039,211 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Sylvester Comprehensive Cancer Center?

ScholarIQresearcher count

Sylvester Comprehensive Cancer Center has 2,457 researchers in the ScholarIQ index.

What is the average h-index at Sylvester Comprehensive Cancer Center?

ScholarIQavg h-index

Sylvester Comprehensive Cancer Center has an average h-index of 63 in OpenAlex.

What is the ROR of Sylvester Comprehensive Cancer Center?

ScholarIQror

The ROR for Sylvester Comprehensive Cancer Center is on the source record.

What is the OpenAlex record for Sylvester Comprehensive Cancer Center?

ScholarIQopenalex

The OpenAlex for Sylvester Comprehensive Cancer Center is on the source record.

Who are the most-cited researchers behind Sylvester Comprehensive Cancer Center?

ScholarIQtop researchers by citations
1
Joseph D. Rosenblatt · Lymphoma Diagnosis and Treatment
385 works17,628 citations

What are the most-cited papers on Sylvester Comprehensive Cancer Center?

ScholarIQmost cited works
B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximab
R. John Looney, Jennifer H. Anolik, Debbie Campbell, Raymond E. Felgar, Faith Young, Lois J. Arend, James A. Sloand, Joseph D. Rosenblatt, Iñaki Sanz
Arthritis & Rheumatism. 2004779 Citations

How much of the research on Sylvester Comprehensive Cancer Center is open access?

ScholarIQopen access share
0%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
0%
Closed
100%

Related on ScholarIQ

470M+ articles · 14-day free trial